Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05692596 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Name: The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics — clinical trial record (NCT05692596)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhaseNot specified

SponsorH. Lee Moffitt Cancer Center and Research Institute

Started2022-10-06

View on ClinicalTrials.gov ↗

The long-term goal of our PIC is to develop effective strategies that can be applied clinically at the point-of-care to prevent, intercept, or detect PDAC at an early stage, thereby reducing PDAC burden and saving lives.

Amendment history 2 changes detected by DataLookout

2026-09-16

Primary completion pushed: 2026-07 → 2027-07

2026-09-16

Completion pushed: 2026-07 → 2027-07

Trial Details

NCT Number	NCT05692596
Lead Sponsor	H. Lee Moffitt Cancer Center and Research Institute
Conditions	Pancreatic Ductal Adenocarcinoma, Pancreatic Cyst, Chronic Pancreatitis, Fatty Pancreas, Genetic Pancreatic Cancer, Genetic Pancreatitis, BRCA Mutation, Lynch Syndrome +5 more
Enrollment	317 participants
Start Date	2022-10-06
Primary Completion	2027-07 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-09-15